Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-07
1996-12-17
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514336, 546193, 5462681, 5462764, C07D40104, A61K 31465
Patent
active
055853889
ABSTRACT:
In accordance with the present invention, there is provided a class of pyridine compounds which are modulators of acetylcholine receptors. The compounds of the invention displace acetylcholine receptor ligands from their binding sites. Invention compounds may act as agonists, partial agonists, antagonists or allosteric modulators of acetylcholine receptors, and are useful for a variety of therapeutic applications, such as the treatment of Alzheimer's disease and other disorders involving memory loss and/or dementia (including AIDS dementia); disorders of attention and focus (such as attention deficit disorder); disorders of extrapyramidal motor function such as Parkinson's disease, Huntington's disease, Gilles de la Tourette syndrome and tardive dyskinesia; mood and emotional disorders such as depression, panic, anxiety and psychosis; substance abuse including withdrawal syndromes and substitution therapy; neuroendocrine disorders and dysregulation of food intake, including bulimia and anorexia; disorders of nociception and control of pain; autonomic disorders including dysfunction of gastrointestinal motility and function such as inflammatory bowel disease, irritable bowel syndrome, diarrhea, constipation, gastric acid secretion and ulcers; pheochromocytoma; cardiovascular dysfunction including hypertension and cardia arrhythmias, comedication in surgical procedures, and the like.
REFERENCES:
patent: 5175301 (1992-12-01), Caldwell et al.
patent: 5212188 (1993-05-01), Caldwell et al.
patent: 5214060 (1993-05-01), Caldwell et al.
patent: 5214152 (1993-05-01), Minamida et al.
patent: 5399575 (1995-03-01), Friebe et al.
patent: 5418229 (1995-05-01), Alker et al.
Alkondon and Albuquerque, "Diversity of Nicotinic Acetylcholine Receptors in Rat Hippocampal Neurons. III. Agonist Actions of the Novel Alkaloid Epibatidine and Analysis of Type II Current" J. Pharmacol. Exper. Therap. 274:771:782 (1995).
Anderson et al., "Characterization of [.sup.3 H]ABT-418: A Novel Cholinergic Channel Ligand" J. Pharmacol. Exper. Therap. 273:1434-1441 (1995).
Chaki et al., "Design and Syntheses of 4-Acylaminopyridine Derivatives: Novel High Affinity Choline Uptake Enchancers I.sup.1 " Bioorgan. & Med. Chem. Let. 5:1489-1494 (1995).
De Fiebre et al., "Characterization of a Series of Anabaseine-Derived Compounds Reveals That the 3-(4)-Dimethylaminocinnamylidine Derivative Is a Selective Agonist at Neuronal Nicotinic .alpha.7/.sup.125 .vertline.-.alpha.-Bungarotoxin Receptor Subtypes" Mol. Pharmacol. 47:164-171 (1995).
Hansson et al., "On the Quantitative Structure--Activity Relationships of Meta-Substituted (S)-Phenylpiperidines, a Class of Preferential Dopamine D.sub.2 Autoreceptor Ligands: Modeling of Dopamine Synthesis and Release in Vivo by Means of Partial Least Squares Regression" J. Med. Chem.38:3121-3131 (1995).
Kashiwabara et al., "Comparative Vasodepressor Effects of 3-Pyridine Derivatives Possessing the Cyanoamidine or Amide Structure in Pithed Rats" Arch. int. Pharmacodyn 328:297-306 (1994).
Natsugari et al., "Novel, Potent, and Orally Active Substance P Antagonists: Synthesis and Antagonist Activity of N-Benzylcarboxamide Derivatives of Pyrido[3,4-b]pyridine" 38:3106-3120 (1995).
Albanese et al., "Chronic Administration of 1-methyl-4-phenyl-1.2.3.6-tetrahydropyridine to Monkeys: Behavioural, Morphological and Biochemical Correlates" Neuroscience 55:823-832 (1993).
Bhattacharjya et al., "Study on Indian Medicinal Plants: Part 91.sup.1 --Structure and Synthesis of Alamaridine, a Novel 5-Methylbenzopyridoquinolizine Alkaloid from Alangium Lamarckii" Tetrahedron 44:3477-3488 (1988).
Borch et al., "The Cyanohydridoborate Anion as a Selective Reducing Agent" J. Am. Chem. Soc. 93:2897-2904 (1971).
Brioni et al., "Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test" European J. Pharm. 238:1-8 (1993).
Burk et al., "Catalytic Asymmetric Reductive Amination of Ketones via Highly Enantioselective Hydrogenation of the C.dbd.N Double Bond" Tetrahedron 50:4399-4428 (1994).
Burk et al., "Preparation and Use of C.sub.2 -Symmetric Bis(phospholanes): Production of .alpha.-Amino Acid Derivatives via Highly Enantioselective Hydrogenation Reactions" J. Am. Chem. Soc. 115:10125-10138 (1993).
Cervinka et al., "Absolute Configuration of .alpha., .beta., .gamma.-Substituted Methylpyridylmethanols and Methylpyridylmethylamines" Asymmetric Reactions. XLVI. 38:1159-1363 (1973).
Cho, B. T. and Chun, Y. S., "Asymmetric Reduction of N-Substituted Ketimines with the Reagent prepared from Borane and (S)--(-)--2-Amino-3-methyl-1,1-diphenylbutan-1-ol (Itsuno's Reagent): Enantioselective Synthesis of Optically Active Secondary Amines" J. Chem. Soc. Perkin Trans 1 3200-3201 (1990).
Christensen et al., "On the Supersensitivity of Dopamine Receptors, Induced by Neuroleptics" Psychopharmcol. 48:1-6 (1976).
Clow et al., "Changes in Dopamine-Mediated Behaviour During One Year's Neuroleptic Administration" European J. Phar. 57:365-375 (1979).
Colautti, A. and Maurich V., "Alchilendiammine N,N'-Bis-sostituite E Basi Di Schiff A Presumible Attivita' Farmacologica" Boll. Chim. Farm. 111:593-597 (1972).
Colpaert, F. C., "Pharmacological Characteristics of Tremor, Rigidity and Hypokinesia Induced by Reserpine in Rat" Neuro. 26:1431-1440 (1987).
Coyle et al., "Kainic Acid: Insights from a Neurotoxin into the Pathophysiology of Huntington's Disease" Neuro. Toxi. Teru. 5:617-624 (1983).
D'Amour, F. E. and Smith, D. L., "A Method for Determining Loss of Pain Sensation" Pharmacol. Exp. Ther. 72:74-79 (1941).
Doll, M. H. and Baker, B. R., "Irreversible Enzyme Inhibitors..sup.1 Inhibitors of Guinea Pig Complement Derived by Quaternization of Substituted Pyridines with Benzyl Halides" J. Med. Chem. 19:1079-1088 (1976).
Dormoy, J. R. and Heymes, A., "Synthese Industrielle en Serie Ellipicine. II.sup.1 " Tetrahedron 49:2915-2938 (1993).
Emerich et al., "Nicotine Potentiates Haloperiodol-Induced Catalepsy and Locomotor Hypoactivity" Pharmucol. Biochem. & Behavior 38:875-880 (1991).
Estrella et al., "A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity" Br. J. Pharmucol. 93:759-768 (1988).
Flynn, D. D. and Mash D. C., "Characterization of .sub.L [.sup.3 H]Nicotine Binding in Human Cerebral Cortex: Comparison Between Alzheimer's Disease and the Normal" J. Neurochem. 47:1948-1954 (1986).
Iwamoto, E. T., "Antinociception after Nicotine Administration into the Mesopontine Tegmentum of Rats: Evidence for Muscarinic Actions.sup.1 " Pharmacol Exp Ther. 251:412-421 (1989).
Janson et al., "Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse" Chin. Investig. 70:232-238 (1992).
Kawate et al., "Asymmetric Reduction of Imines with Chiral Dialkoxyboranes" Tetrahedron Asym. 3:227-230 (1992).
Kitamura et al., "General Asymmetric Synthesis of Isoquinoline Alkaloids. Enantioselective Hydrogenation of Enamides Catalyzed by Binap-Ruthenium (II) Complexes" J. Org. Chem. 59:297-310 (1994).
Klockgether, T. and Turski, L., "NMDA Antagonists Potentiate Antiparkinsonian Actions of .sub.L -Dopa in Monoamine-depleted Rats" Ann Neurol. 28:539-546 (1990).
Masner et al., "Novel Inhibiors of Sterol C-14 Demethylase and .DELTA..sup.14 Reductase/.DELTA..sup.8 .fwdarw..DELTA..sup.7 Isomerase for Cereal Disease Control" Pestic Sci 35:339-347 (1992).
Mathre et al., "A Practical Process for the Preparation of Tetrahydro-1-methyl-3,3-diphenyl-1H,3H-pyrrolo[1,2-c]--[1,3,2]oxazaborole- Borane. A Highly Enantioselective Stoichiometric and Catalytic Reducing Agent" J. Org. Chem. 58:2880-2888 (1993).
McDonald et al., "Enzyme-Activated Irreversible Inhibitors of Monoamine Oxidase: Phenylallylamine Structure-Activity Relationships" J. Med. Chem. 28:186-193 (1985).
McDonald, I. A. and Bey, P., "A General Preparation of Fluoroallylamine Enzyme Inhibitors Incorporating a .beta.-Substituted Heteroatom" Tetrahedron Lett. 26:3807-3810 (1985).
Minamida et al., "Synthesis and Insec
Cosford Nicholas D.
Vernier Jean-Michel
Davis Zinna Northington
Reiter Stephen E.
SIBIA Neurosciences Inc.
LandOfFree
Substituted pyridines useful as modulators of acetylcholine rece does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyridines useful as modulators of acetylcholine rece, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyridines useful as modulators of acetylcholine rece will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991558